What is it about?

n/a

Featured Image

Read the Original

This page is a summary of: Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis, Journal of the American Society of Nephrology, May 2024, Wolters Kluwer Health,
DOI: 10.1681/asn.0000000000000386.
You can read the full text:

Read

Contributors

The following have contributed to this page